Načítá se...
Pharmacotherapy for Non-alcoholic Fatty Liver Disease
Life style modifications and optimization of the management of cardio-metabolic comorbidities are currently the mainstay of treatment for patients with non-alcoholic fatty liver disease (NAFLD). Pharmacotherapy to halt or reverse hepatic histological injury and prevent the development of end stage l...
Uloženo v:
| Vydáno v: | Semin Liver Dis |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5401764/ https://ncbi.nlm.nih.gov/pubmed/26378648 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0035-1562951 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|